Article info

Original research
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses
Free

Authors

  1. Correspondence to Dr Houssein H Ayoub, Department of Mathematics, Statistics, and Physics, Qatar University, P.O. Box 2713, Doha, Qatar; hayoub{at}qu.edu.qa; Dr Laith J Abu-Raddad, Infectious Disease Epidemiology Group, World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine—Qatar, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar; lja2002{at}qatar-med.cornell.edu
View Full Text

Citation

Ayoub HH, Chemaitelly H, Makhoul M, et al
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses

Publication history

  • Received January 9, 2021
  • Revised March 8, 2021
  • Accepted March 15, 2021
  • First published March 31, 2021.
Online issue publication 
April 19, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.